Chemotherapy can contribute to scarring indirectly by causing inflammation and tissue damage. Certain chemotherapeutic agents are more likely to cause fibrosis as a side effect. For instance, bleomycin is known to cause pulmonary fibrosis in some patients. Monitoring and managing these side effects are crucial to prevent significant long-term damage.
